<DOC>
	<DOCNO>NCT00857688</DOCNO>
	<brief_summary>To evaluate efficacy product Bismu-Jet Â® ( bismuth tartrate sodium , neomycin sulfate procaine hydrochloride ) produce EMS S / A compare placebo reduce sign symptom result UAR patient sex , age 12 year .</brief_summary>
	<brief_title>Efficacy Combination Bismuth + Neomycin + Procaine Treatment Recurrent Aphthous Ulceration</brief_title>
	<detailed_description>The period practical study conduct Center Orofacial Rehabilitation Aesthetics , locate Campinas-SP , several bed large number people serve dentist attend post-graduate , supervision Dr. Claudio Azenha . Thus , patient instruct find center experience first sign UARs . Will include top table extrapolate 48 hour . These patient refer visit screen early treatment ( day 0 - Visit 01 ) . At screen visit inform relevant aspect research , enable patient judge feasibility participation study . After sign Informed Consent , patient randomize receive one treatment . This consultation clinical examination examiner tell lesion measure size . Besides clinical examination subjective test , patient must consider intensity pain 're feel moment , use visual analogue scale ( VAS ) . The drug administer investigator , patient show correct way administration . After 15 minute , pain measure , use VAS . After three day , patient return 02 tour , clinically evaluate assessed intensity pain , addition report adverse event . The procedure repeat return seven day ( Visit 03 ) . This visit patient may receive high clinic . The study finalize 14 day treatment ( Visit 04 ) , patient must return office final evaluation , high exempt clinical study . Patients improvement time , receive replacement therapy fund sponsor provide waxen , accord need individual case , judge expert researcher .</detailed_description>
	<mesh_term>Bismuth</mesh_term>
	<mesh_term>Neomycin</mesh_term>
	<mesh_term>Procaine</mesh_term>
	<criteria>Consistency purpose study topic FICT ; Age 12 year ; Both sex ; Diagnosis type UAR minor Use nutritional supplement iron , folic acid vitamin B complex ; immunocompromised ; systemic disease ( endocrinemetabolic ) ; rheumatic disease ; Pregnancy lactation ; Use topical systemic corticosteroid ; UAR type major ; UAR type Herpetiformis ; UAR 48 hour development ; Background allergic component formula .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>aphtous</keyword>
	<keyword>bismuth</keyword>
	<keyword>procain</keyword>
	<keyword>neomycin</keyword>
	<keyword>Efficacy Association Treatment Aphtous</keyword>
</DOC>